Dynamics of Weight Change and Glycemic Control in Patients with Type 2 Diabetes Treated with Exenatide or Insulin

被引：0
|
作者：
Paul, Sanjoy K.
Best, Jennie H.
Naughton, Margaret
Maggs, David
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [41] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
    Riddle, Matthew
    Zhang, Bei
    Maier, Holly
    Wilhelm, Ken
    Kolterman, Orville
    DIABETES, 2008, 57 : A156 - A156
  • [42] Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents
    Davis, Stephen N.
    Johns, Don
    Maggs, David
    Xu, Hangtao
    Northrup, Justin H.
    Brodows, Robert G.
    DIABETES CARE, 2007, 30 (11) : 2767 - 2772
  • [43] Evolution over 9 months in glycemic patients with type 2 diabetes benefited from the replacement of insulin by exenatide
    Martin, M.
    Sanchis, S. Boullu
    Sigrist, S.
    Moreau, F.
    Lucescu, C.
    Pinget, M.
    Jeandidier, N.
    DIABETES & METABOLISM, 2010, 36 : A81 - A81
  • [44] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    Buse, JB
    Henry, RR
    Han, J
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETES CARE, 2004, 27 (11) : 2628 - 2635
  • [45] The Relationship of Recurrent Hypoglycemia with Glycemic Control and Insulin Change in Patients Treated with Insulin Glargine and Exenatide Twice Daily vs. Insulin Lispro or Placebo
    Strand, Jorma
    Gouet, Didier
    Han, Jenny
    Ruggles, James
    Zhuplatov, Sergey
    DIABETES, 2015, 64 : A645 - A645
  • [46] The prevalence of glycemic control in patients with type 2 diabetes treated with insulin: a systematic review and meta-analysis
    Pitak, P.
    Tasai, S.
    Kumpat, N.
    Songkla, P. Na
    Fuangchan, A.
    Krass, I.
    Dhippayom, T.
    PUBLIC HEALTH, 2023, 225 : 218 - 228
  • [47] Association Between Triglyceride Level and Glycemic Control Among Insulin-Treated Patients With Type 2 Diabetes
    Zheng, Deqiang
    Dou, Jingtao
    Liu, Guangxu
    Pan, Yuesong
    Yan, Yuxiang
    Liu, Fen
    Gaisano, Herbert Y.
    Lu, Juming
    He, Yan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (04): : 1211 - 1220
  • [48] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
    Kendall, DM
    Riddle, MC
    Rosenstock, J
    Zhuang, DL
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETES CARE, 2005, 28 (05) : 1083 - 1091
  • [49] Insulin glulisine provides improved glycemic control in patients with type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, RG
    Ways, K
    DIABETES CARE, 2004, 27 (10) : 2363 - 2368
  • [50] Exenatide added to insulin glargine-treated patients with type 2 diabetes provided excellent fasting and postprandial control with weight loss and no increased risk of hypoglycaemia
    Bergenstal, R. M.
    Buse, J. B.
    Glass, L. C.
    Heilmann, C. R.
    Lewis, M. S.
    Kwan, A. Y. M.
    Hoogwerf, B. J.
    Rosenstock, J.
    DIABETOLOGIA, 2010, 53 : S37 - S37
12345